Baysal Leyla, Jobi Sabrina, Zimmermann Simone, Helmers Ann-Kristin, Margraf Nils Gerd
Epilepsy Center, Department of Neurology, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, 24105 Kiel, Germany.
Department of Neurosurgery, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, 24105 Kiel, Germany.
Epilepsy Behav Rep. 2025 Apr 14;30:100769. doi: 10.1016/j.ebr.2025.100769. eCollection 2025 Jun.
Myoclonic epilepsy with ragged red fibers (MERRF) syndrome is a rare mitochondrial disorder marked by myoclonus, ataxia, cognitive impairment, myopathy, and sensorineural hearing loss. Seizures in MERRF syndrome are often resistant to standard antiseizure medication. We present a unique case of an adult patient with MERRF syndrome, caused by the m.8344A > G point mutation, who developed super-refractory status epilepticus (SRSE), successfully managed by the initiation and rapid escalation of vagus nerve stimulation (VNS) therapy. Over a two-year follow-up period, the VNS therapy enabled a long-term control of generalized tonic-clonic seizures. A further status epilepticus has not yet occurred. VNS may therefore be a promising therapeutic option for managing SRSE in patients with mitochondrial epilepsy syndromes.
肌阵挛性癫痫伴破碎红纤维(MERRF)综合征是一种罕见的线粒体疾病,其特征为肌阵挛、共济失调、认知障碍、肌病和感音神经性听力损失。MERRF综合征的癫痫发作通常对标准抗癫痫药物耐药。我们报告了一例由m.8344A>G点突变引起的成年MERRF综合征患者的独特病例,该患者发生了超难治性癫痫持续状态(SRSE),通过启动并迅速升级迷走神经刺激(VNS)治疗成功得到控制。在两年的随访期内,VNS治疗实现了对全身强直阵挛性发作的长期控制。尚未再次发生癫痫持续状态。因此,VNS可能是治疗线粒体癫痫综合征患者SRSE的一种有前景的治疗选择。